Mari Kogo
Impact in
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacy and Medical Practices
Papers in
- Oncology 17
- Neutropenia and Cancer Infections 5
-
- Lung Cancer Treatments and Mutations 3
- Renal cell carcinoma treatment 2
- Co-authors
- Yuji Kiuchi (24 shared papers)Michio Imawari (11 shared papers)Toshinori Yamamoto (9 shared papers)Kazuhiro Kaneko (4 shared papers)Kazuo Konishi (4 shared papers)Tatsuya Kurihara (12 shared papers)Masayuki Ohbayashi (7 shared papers)Yasuna Kobayashi (3 shared papers)
- Journals
- Hepatogastroenterology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Chemotherapy (2 papers)Digestive Diseases and Sciences (2 papers)Advances in Therapy (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Mari Kogo
50 papers receiving 305 citations
Peers
Comparison fields: 5 of 69
- Pharmacology 44
- Applied Microbiology and Biotechnology 9
- Geriatrics and Gerontology 15
- Oncology 101
- Hepatology 19
Countries citing papers authored by Mari Kogo
This map shows the geographic impact of Mari Kogo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Kogo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Kogo more than expected).
Fields of papers citing papers by Mari Kogo
This network shows the impact of papers produced by Mari Kogo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Kogo. The network helps show where Mari Kogo may publish in the future.
Co-authors
The 25 scholars most cited alongside Mari Kogo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 37 | |
| 2 | 2018 | 29 | |
| 3 | 2013 | 22 | |
| 4 | Role of CYP2C19 in stereoselective hydroxylation of mephobarbital by human liver microsomes. | 2001 | 20 |
| 5 | 2014 | 17 | |
| 6 | 2012 | 15 | |
| 7 | 2015 | 14 | |
| 8 | Analysis of the risk factors for myelosuppression after chemoradiotherapy involving 5-fluorouracil and platinum for patients with esophageal cancer. | 2011 | 14 |
| 9 | 2005 | 13 | |
| 10 | 2006 | 9 | |
| 11 | 2007 | 8 | |
| 12 | 2009 | 8 | |
| 13 | 2007 | 8 | |
| 14 | 2017 | 6 | |
| 15 | Practical prognostic index for survival in patients with unresectable pancreatic cancer treated with gemcitabine or S-1. | 2015 | 5 |
| 16 | 2020 | 5 | |
| 17 | 2017 | 5 | |
| 18 | 2022 | 4 | |
| 19 | 2017 | 4 | |
| 20 | 2013 | 4 |
About Mari Kogo
Mari Kogo is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pharmacology, Hepatology and Surgery, having authored 58 papers that have together received 311 indexed citations. Recurring topics across this work include Pharmacy and Medical Practices (9 papers), Neutropenia and Cancer Infections (5 papers), Pharmaceutical Practices and Patient Outcomes (4 papers), Safe Handling of Antineoplastic Drugs (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Liver Disease and Transplantation (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Pharmacology (44 citations), Applied Microbiology and Biotechnology (9 citations), Geriatrics and Gerontology (15 citations), Oncology (101 citations) and Hepatology (19 citations). Mari Kogo has collaborated with scholars based in Japan and United States. Frequent co-authors include Yuji Kiuchi, Michio Imawari, Toshinori Yamamoto, Kazuhiro Kaneko, Kazuo Konishi, Tatsuya Kurihara, Masayuki Ohbayashi, Yasuna Kobayashi, Noriko Kohyama and Keiji Mitamura. Their work appears in journals such as Hepatogastroenterology, Cancer Chemotherapy and Pharmacology, Chemotherapy, Digestive Diseases and Sciences and Advances in Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.